Detalhe da pesquisa
1.
An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3.
Cytogenet Genome Res
; 161(10-11): 479-487, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915466
2.
The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
Turk J Haematol
; 39(4): 237-244, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199265
3.
A pediatric BAL case with double Ph chromosomes and trisomy 5.
Cancer Genet
; 258-259: 7-9, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225100
4.
A new four-way complex translocation variant involving the t(8;5;21;4)(q21;q13,q22,q31) and the relocalization of AML1/ETO fusion gene.
Cancer Genet
; 256-257: 1-4, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773407
5.
Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
Mol Cytogenet
; 14(1): 2, 2021 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407772